Henrik Toft Sørensen is professor of clinical epidemiology, and is founder and chair of Department of Clinical Epidemiology at Aarhus University Hospital, which was established in 2000. He is a physician and specialist in internal medicine and hepatology, has trained at several major Danish hospitals and acted as a clinician until 2005. He has been affiliated with Boston University since 2005.
Dr. Sørensen has more than 25 years of experience in clinical and epidemiological research. His research covers, among others, pharmacoepidemiology, epidemiological methods and determinants of the prognosis of several chronic diseases. Dr. Sørensen is author or co-author of more than 1,400 publications and has been supervisor for more than 60 doctoral students. He is Editor in Chief of Clinical Epidemiology.
Aarhus University Hospital
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 1499 results.
Kristensen FPB, Christensen DH, Callaghan BC, Stidsen JV, Nielsen JS, Højlund K, Beck-Nielsen H, Jensen TS, Andersen H, Vestergaard P, Jessen N, Olsen MH, Hansen T, Brøns C, Vaag A, Sørensen HT, Thomsen RW. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of ß-Cell Function and Insulin Sensitivity. Diabetes Care. 2023 Aug 01; 46(8):1546-1555. PMID: 37335990
Schmidt M, Arendt-Nielsen L, Hauge EM, Sørensen HT, Pedersen L. High- vs. low-dose diclofenac and cardiovascular risks: a target trial emulation. Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29; 9(5):453-461. PMID: 36921986
Kristensen FPB, Christensen DH, Mortensen MB, Maeng M, Kahlert J, Sørensen HT, Thomsen RW. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study. Cardiovasc Diabetol. 2023 Jul 26; 22(1):187. PMID: 37495999; PMCID: PMC10373341; DOI: 10.1186/s12933-023-01921-5;
Bonnesen K, Heide-Jørgensen U, Sørensen HT, Schmidt M. Ability of the DANCAMI to predict the risk ischemic stroke and mortality in patients with atrial fibrillation/flutter. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107219. PMID: 37453409
Thomsen MK, Jørgensen MD, Pedersen L, Erichsen R, Sørensen HT, Mikkelsen EM. Mental disorders, participation, and trajectories in the Danish colorectal cancer programme: a population-based cohort study. Lancet Psychiatry. 2023 Jul; 10(7):518-527. PMID: 37353263
Gadgaard NR, Varnum C, Nelissen RGHH, Vandenbroucke-Grauls C, Sørensen HT, Pedersen AB. Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study. Osteoporos Int. 2023 Oct; 34(10):1739-1749. PMID: 37330437
Hvitfeldt Fuglsang C, Pedersen L, Schmidt M, Vandenbroucke JP, Bøtker HE, Sørensen HT. Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study. PLoS Med. 2023 Jun; 20(6):e1004238. PMID: 37310926; PMCID: PMC10263301; DOI: 10.1371/journal.pmed.1004238;
Hansen AL, Thomsen RW, Brøns C, Svane HML, Jensen RT, Andersen MK, Hansen T, Nielsen JS, Vestergaard P, Højlund K, Jessen N, Olsen MH, Sørensen HT, Vaag AA. Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes. Diabetologia. 2023 Sep; 66(9):1680-1692. PMID: 37303007; PMCID: PMC10390374; DOI: 10.1007/s00125-023-05936-1;
Bonnesen K, Pedersen L, Ehrenstein V, Sørensen HT, Lash TL, Schmidt M. Impact of hemoglobin A1c level on the association between non-steroidal anti-inflammatory drug use and cardiovascular events in patients with type 2 diabetes: A population-based cohort study. Pharmacoepidemiol Drug Saf. 2023 Jun 09. PMID: 37294526